Spectranetics Receives FDA Clearance for Cross-Pilot Product

Spectranetics Corp. has received clearance from the US Food and Drug Administration (FDA) for its Cross-Pilot laser support catheter. The product will be launched during the first quarter of 2009 within the US, Europe and Canada. The Cross-Pilot is a laser support catheter for the 0.9 Turbo Elite laser ablation catheter, and was designed to provide additional support for reaching distal lesions. The braid reinforced catheter construction and hydrophilic coating allow for better pushability through distal vessels and the angled tip allows for quicker access to branched anatomy. Cross-Pilot is currently offered in a 125-cm length and straight and angled tip configurations. Spectranetics is located in Colorado Springs, Colo., and manufactures the only excimer laser approved in the US, Europe and Japan for use in minimally invasive cardiovascular procedures.